Vimarsana
Biggest News Aggregation in the World

Simon Jose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simon Jose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simon Jose Today - Breaking & Trending Today

GNW-Adhoc: Idorsia announces a change to commercial leadership - Vimarsana News

GNW-Adhoc: Idorsia announces a change to commercial leadership

^Ad hoc announcement pursuant to Art. 53 LR * Simon Jose to step down from his position as Chief Commercial Officer and member of the Idorsia Executive Committee to pursue other opportunities * Otto Schwarz will advise the management team on commercial operations Allschwil, Switzerland - May 30,...

Idorsia Pharmaceuticals Ltd: Idorsia announces a change to commercial leadership - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces a change to commercial leadership

Ad hoc announcement pursuant to Art. 53 LR Simon Jose to step down from his position as Chief Commercial Officer and member of the Idorsia Executive Committee to pursue other opportunitiesOtto Schwarz

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 25, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2023. Commercial highlights QUVIVIQ

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for 2022 - building momentum to become a leading mid-sized biopharmaceutical company - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for 2022 - building momentum to become a leading mid-sized biopharmaceutical company

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - February 7, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2022. Commercial highlights QUVIVIQ

QUVIVIQ (daridorexant) – Europe's first dual orexin - Vimarsana News

QUVIVIQ (daridorexant) – Europe's first dual orexin

QUVIVIQ™ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact...